Hans-Joachim Schmoll

Klinik fur Innere Med IV, University Clinic Halle, Germany

Hans-Joachim Schmoll

Academic positions:
- Director, University Hospital for Internal Medicine IV, Oncology/Hematology
- Chairman of the German Association of Medical Oncology
- President of the Cancer Society of the German State of Sachsen-Anhalt.
- Temporary Director of the Clinical Institute for Chemistry and Pathobiochemistry
- Professor of Internal Medicine
- Director of the Department of Haematology and Oncology at the Martin-Luther-University Halle-Wittenberg

Any industry positions (last five years):
Professor Schmoll has been on advisory boards for Sanofi-Aventis, Astra Zeneca and Hoffmann-La Roche

Research interests:

Any other information:
- Founding Chairman of the Cancer Society of Sachsen-Anhalt
- Member of the advisory board of the European Society for Medical Oncology (ESMO).
- Chairman of the Urological Group of the German Cancer Society
- Chairman of the German Association of Medical Oncology;
- President of the Cancer Society of the German State of Sachsen-Anhalt.
- Member of the European Organisation for Research and Treatment of Cancer (EORTC)
- Member of numerous other international oncology societies, including the American Society for Medical Oncology (ASCO).
- Member of the editorial board of numerous scientific journals such as the European Journal of Cancer, the Annals of Oncology and Onkologie.
- Awarded the Johann-Georg-Zimmermann-award for Cancer research 1981
- Awarded the German Cancer award 2001

Any competing interests declared are displayed with individual evaluations.

Section Head: Oncology > Genitourinary Cancers (since 16 November 2005)

Hans-Joachim Schmoll is a Section Head for Genitourinary Cancers, part of the ONCOLOGY Faculty. The role of a Section Head is to work with their Co-Section Head(s) to divide the Section (sub-specialty area) into its component areas of research, nominate leaders in those areas as Faculty Members, and offer ongoing oversight of the content within their Section. They are not asked to evaluate articles, although we do, of course, welcome them.